References:1.Criteria Specification Registry. (n.d.).
https://cspec.genome.network/cspec/ui/svi/affiliation/500162. Billings LK, Shi Z, Resurreccion WK, Wang CH, Wei J, Pollin TI, Udler MS, Xu J. Statistical evidence for high-penetrance MODY-causing genes in a large population-based cohort. Endocrinol Diabetes Metab. 2022 Nov;5(6):e372
3. ADA Guidelines: American Diabetes Association Professional Practice Committee (2024). Introduction and Methodology: Standards of Care in Diabetes-2024.
Diabetes care,
47(Supplement_1), S1–S4.
https://doi.org/10.2337/dc24-SINT4. Billings LK, Shi Z, Wei J, Rifkin AS, Zheng SL, Helfand BT, Ilbawi N, Dunnenberger HM, Hulick PJ, Qamar A, Xu J. Utility of Polygenic Scores for Differentiating Diabetes Diagnosis Among Patients With Atypical Phenotypes of Diabetes. J Clin Endocrinol Metab. 2023 Dec 21;109(1):107-113
5. Billings LK, Shi Z, Mulford AJ, Wei J, Tran H, Ashworth A, Zheng SL, Dunnenberger HM, Hulick PJ, Sanders AR, Xu J. Validation of GenProb[1]T1D and its clinical utility for differentiating types of diabetes in a biobank from a US healthcare system. J Diabetes Investig. 2024 Aug 22